BPOM EXPLANATION RELATED TO NDMA CONTENT

Head of Drug and Food Supervisory Agency (BPOM) Penny K Lukito (center) accompanied by Head of Advocacy Association of Doctors in Indonesia (PAPDI) dr Prasetyo Widhi Buwono (second right), Ketum Managing Center for Indonesian Apoteker Association (PP IAI) Nurul Falah (second left), Chairman of the Indonesian Doctor's Association of Drug Policy Committee (PB IDI) dr Rika Yuliwulandari (kanan), and Deputy BPOM RitaND End (left) gave a press related to the results of NMA-Nitro) drug containing products in Randin (M) Based on the review of the test results that have been conducted until October 9, 2019 against the presence of the NDMA pollutants on the ranitidin product, BPOM ordered the whole pharmaceutical industry of ranitidin’s license holder to stop while production, distribution and distribution in order to be careful to protect the society. ANTARA PHOTO/Aprillio Akbar/foc.

The caption is automatically translated by application. Click here for the Bahasa Indonesia version.